Dividend
-
-
-
-
-
-
-
Cipher Pharmaceuticals Announces Management Change
-
-
-
-
-
-
-
Cipher Pharmaceuticals Out-Licenses Rights to ASF-1096 for Anorectal Disorders
-
-
-
-
-
-
-
Cipher Pharma's (CPHR) Dermadexin and Pruridexin Approved in Canada
-
-
-
-
-
-
-
Cipher Pharmaceuticals Inc. announces Canadian launch of Actikerallâ„¢
-
-
-
-
-
-
-
Cipher announces settlement in patent litigation for Absorica®
-
-
-
-
-
-
436,668 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

